Zepp Health Co. (NYSE:ZEPP – Get Free Report)’s stock price dropped 5.2% on Tuesday . The stock traded as low as $2.80 and last traded at $2.89. Approximately 9,017 shares traded hands during mid-day trading, a decline of 52% from the average daily volume of 18,976 shares. The stock had previously closed at $3.05.
Wall Street Analysts Forecast Growth
Separately, Fundamental Research set a $14.65 price target on shares of Zepp Health and gave the stock a “buy” rating in a report on Tuesday, November 26th.
Read Our Latest Stock Analysis on ZEPP
Zepp Health Stock Down 1.1 %
Hedge Funds Weigh In On Zepp Health
A hedge fund recently bought a new stake in Zepp Health stock. Virtu Financial LLC purchased a new stake in Zepp Health Co. (NYSE:ZEPP – Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 13,056 shares of the company’s stock, valued at approximately $57,000. Virtu Financial LLC owned about 0.09% of Zepp Health at the end of the most recent reporting period. 52.61% of the stock is currently owned by institutional investors.
Zepp Health Company Profile
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.
Recommended Stories
- Five stocks we like better than Zepp Health
- Health Care Stocks Explained: Why You Might Want to Invest
- Micron Stock Under $100: Seize the AI-Driven Upside
- Why is the Ex-Dividend Date Significant to Investors?
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- What is the Hang Seng index?
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.